Laurie J. Hall Trustee’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-510
Closed -$1K 323
2022
Q3
$1K Hold
510
﹤0.01% 316
2022
Q2
$1K Hold
510
﹤0.01% 317
2022
Q1
$1K Hold
510
﹤0.01% 322
2021
Q4
$1K Hold
510
﹤0.01% 324
2021
Q3
$2K Sell
510
-310
-38% -$1.49K ﹤0.01% 318
2021
Q2
$5K Hold
820
﹤0.01% 306
2021
Q1
$6K Hold
820
﹤0.01% 307
2020
Q4
$4K Hold
820
﹤0.01% 314
2020
Q3
$5K Buy
+820
New +$4.91K ﹤0.01% 295
2019
Q4
$3K Buy
+290
New +$2.11K ﹤0.01% 317

Other funds holding CLVS

Laurie J. Hall Trustee's CLVS Position: Q4 2022 in Review

Laurie J. Hall Trustee sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 510 shares — an estimated $1K sold.

Laurie J. Hall Trustee first reported a position in CLVS in Q4 2019 and held it in 10 quarters. The position peaked at $6K in Q1 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Laurie J. Hall Trustee reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 510 Clovis Oncology, Inc. shares in Q4 2022, an estimated $1K.
  • Laurie J. Hall Trustee first reported a position in Clovis Oncology, Inc. in Q4 2019 and held it in 10 quarters.
  • Laurie J. Hall Trustee's Clovis Oncology, Inc. position peaked at $6K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Laurie J. Hall Trustee's 13F filing for Q4 2022, filed 11 Jan 2023.